Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial-Reference-Cited by-同舟云学术

Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial

Published:2021-08 Issue: Volume:109 Page:114-117
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Hamilton F.W.,Lee Todd,Arnold D.T.,Lilford R.,Hemming K.

Funder

Wellcome Trust

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19;Lundgren;N Engl J Med,2021

2. Efficacy of convalescent plasma therapy compared to fresh frozen plasma in severely ill COVID-19 patients: A pilot randomized controlled trial;Bajpai,2020

3. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19;Chen;N Engl J Med,2021

4. Use of convalescent plasma therapy in SARS patients in Hong Kong;Cheng;Eur J Clin Microbiol Infect Dis,2005

5. Convalescent Plasma COVID-19 Emergency Use Authorization,2021

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial;Transfusion;2024-03-21

2. COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients;Scientific Reports;2023-12-01

3. Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID;MedComm;2023-11-15

4. The emergency use authorization for COVID‐19 convalescent plasma reduced mortality;Health Science Reports;2023-08

5. Cost-Effectiveness of Convalescent Plasma for COVID-19: A Cost-effectiveness Analysis of the CONCOR-1 Randomized Trial;2023-07-06